Navigation Links
Herding cancer cells to their death
Date:6/20/2013

June 20, 2013, New York, NY and Oxford, UK An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors. This cellular heterogeneity is what makes advanced tumors so difficult to treat. Publishing their findings in today's online issue of Cancer Cell, an international team of scientists led jointly by Professors Colin Goding from the Ludwig Institute for Cancer Research who is based at the University of Oxford and Jos Neptuno Rodriguez-Lpez from the University of Murcia, Spain describe a therapeutic strategy that manipulates a mechanism driving that heterogeneity to treat advanced melanoma. Their preclinical studies show that the strategy, which employs a new drug-like molecule in combination with an existing chemotherapy, is highly specific to melanoma cells and effective against tumors that resist all other therapies.

If caught early, melanoma is relatively easy to treat. But in its late stages, it is a stubborn and deadly cancer. Until about a decade ago, patients survived only about seven months after starting treatment. Since then, therapies, such as vemurafenib, that specifically target signaling proteins essential to the proliferation and survival of melanoma cells have extended the lives of some patients. But only about half respond to these targeted therapies, and even in those patients the cancer begins to resist the targeted therapy within six to nine months.

To bypass such resistance, the researchers developed a strategy that essentially pushes subtypes of melanoma cells that are not dividingand are therefore not susceptible to chemotherapyto become vulnerable to a shrewdly targeted drug.

To develop their therapy, the scientists first screened a variety of molecules to find one that boosts the expression of MITF, a master gene that, at high levels, pushes melanoma cell
'/>"/>

Contact: Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. No danger of cancer through gene therapy virus
2. An article in Cell reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer
3. Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors
4. Using math to kill cancer cells
5. Gene variants may predict who will benefit from breast cancer prevention drugs
6. Nanotechnology helps track and improve drug action in pancreatic cancer
7. Biomarker identification may lead to new noninvasive test for colorectal cancer detection
8. First dual-action compound kills cancer cells, stops them from spreading
9. New Research: Modified Citrus Pectin - A Potent Anti-Cancer Therapy
10. U of A medical researchers ID genetic marker for sporadic breast cancer
11. Modulating the immune system to combat metastatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint ... FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World Peace ... of FPC,s distributors in Asia . Deliveries ... The sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of approximately 2,200 ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... stimulation identified areas of the brain responsible for starting locomotion, ... vertebrate until now. To find this ... Biological Sciences studied a small, simple vertebrate: the Xenopus ... to initiate swimming consists of just four types of neurons. ...
... , This release is available in Spanish . ... trees in the Mediterranean region, many experts have claimed that they ... to verify this," as explained to SINC by the ecologist Bernat ... A team from this centre has now analysed the ...
... 2012 Cardium Therapeutics (NYSE Amex: CXM) today announced ... Gene & Cell Therapy (ASGCT) 15th Annual Meeting being ... in Philadelphia, PA. The new ... role in adenovector gene transfection (delivery) in mammalian hearts. ...
Cached Biology News:The millennium-old olive trees of the Iberian Peninsula are younger than expected 2Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial 2
(Date:8/3/2015)... ... August 03, 2015 , ... Nine field days to ... and Indiana. Hosted by the Soil Health Partnership , the field days will ... benefits while potentially increasing farm productivity and income. , Brent Bible has practiced no-till ...
(Date:8/3/2015)... 3, 2015 According to a ... Cell Culture: Asia to Witness ... the global 3D cell culture market was valued at US$ 586.1 ... a CAGR of 29.1% to account for US$ 2,717.6 ... TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture refers ...
(Date:7/31/2015)... Dallas, Texas (PRWEB) , ... July 31, 2015 ... ... research report, offering competitive market analysis and premium industry insights on the global ... challenges, based on a collective study of vivid market scenarios and analysis of ...
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
Breaking Biology Technology:Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4
... the market and business intelligence company, contract biomanufacturing is a significant ... of about 10 to 15%. Pharmaceutical biomanufacturing could account for more ... , ... Paris, France (PRWEB) September 15, 2008 -- Biologics ...
... the SolvayCARES Thriving Student ... Goals -, MARIETTA, Ga., Sept. 15 Solvay ... living with,cystic fibrosis (CF) through its SolvayCARES Scholarship program. ... help finance,post-secondary education. This fall, one SolvayCARES Scholarship winner,will ...
... Harvard Deploys Isilon Clustered Storage to Manage ... SEATTLE, Sept. 15 Isilon(R) Systems (Nasdaq:,ISLN), ... the Broad,Institute of MIT and Harvard, one of ... deployed Isilon IQ clustered storage to,streamline mission-critical data ...
Cached Biology Technology:CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market 2CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market 340 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 240 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 340 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 4Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 2Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing 3
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
LAL Chromogenic Endpoint assay...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
...
Biology Products: